tiprankstipranks
Shanghai Chicmax Cosmetics Co., Ltd. Class H (HK:2145)
:2145
Hong Kong Market
Want to see HK:2145 full AI Analyst Report?

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) AI Stock Analysis

1 Followers

Top Page

HK:2145

Shanghai Chicmax Cosmetics Co., Ltd. Class H

(2145)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - Gpt-5.6Sol)
Rating:75Outperform
Price Target:
HK$25.00
â–¼(-37.47% Downside)
Action:Reiterated
Date:08/19/26
Strong financial performance and very attractive valuation (low P/E and high dividend yield) support the score. This is partially offset by weak technical positioning, with the stock trading below all major moving averages and only neutral momentum signals.
Positive Factors
Renewed Revenue Growth
The sharp acceleration in 2025 revenue indicates renewed demand and improved execution after a softer prior year. Sustained growth would strengthen operating leverage, support brand investment, and expand the company’s competitive position in China’s beauty market.
Negative Factors
Incomplete Cash Conversion
Profit growth has not fully translated into cash, which may reflect working-capital needs or other non-cash earnings factors. Persistent conversion gaps could constrain reinvestment, dividends, and balance-sheet flexibility even if reported profitability remains strong.
Read all positive and negative factors
Positive Factors
Negative Factors
Renewed Revenue Growth
The sharp acceleration in 2025 revenue indicates renewed demand and improved execution after a softer prior year. Sustained growth would strengthen operating leverage, support brand investment, and expand the company’s competitive position in China’s beauty market.
Read all positive factors

Shanghai Chicmax Cosmetics Co., Ltd. Class H (2145) vs. iShares MSCI Hong Kong ETF (EWH)

Shanghai Chicmax Cosmetics Co., Ltd. Class H Business Overview & Revenue Model

Company Description
Shanghai Chicmax Cosmetic Co., Ltd. is a multifaceted beauty corporation based in China, specializing in the entire product lifecycle—from innovation and production to market distribution—for skincare, as well as maternity and infant care lines. T...
How the Company Makes Money
Chicmax primarily makes money by selling cosmetics and personal care products to consumers, generating revenue from product sales across its portfolio. Key revenue streams typically include (1) direct-to-consumer sales via online platforms (includ...

Shanghai Chicmax Cosmetics Co., Ltd. Class H Financial Statement Overview

Summary
Strong and improving profitability with expanding gross and net margins, plus renewed 2025 revenue growth. Balance sheet leverage is currently conservative and ROE is very strong, but historical leverage swings and moderate cash conversion (OCF and FCF trailing net income) temper the score.
Income Statement
86
Very Positive
Balance Sheet
82
Very Positive
Cash Flow
74
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue9.18B6.79B4.19B2.68B3.62B
Gross Profit7.00B5.11B2.99B1.70B2.36B
EBITDA1.21B752.09M676.04M268.88M404.70M
Net Income1.10B781.21M461.10M147.10M338.89M
Balance Sheet
Total Assets4.97B3.60B3.13B3.15B2.27B
Cash, Cash Equivalents and Short-Term Investments958.21M732.71M914.50M1.17B157.26M
Total Debt632.47M111.67M165.57M728.20M285.04M
Total Liabilities2.09B1.36B1.10B1.44B1.32B
Stockholders Equity2.77B2.19B2.01B1.71B949.98M
Cash Flow
Free Cash Flow690.54M304.38M657.69M-23.51M269.46M
Operating Cash Flow1.21B546.95M746.16M36.56M335.19M
Investing Cash Flow-448.86M-187.03M-457.49M-66.78M-55.29M
Financing Cash Flow-404.82M-595.67M-737.21M1.03B-289.56M

Shanghai Chicmax Cosmetics Co., Ltd. Class H Technical Analysis

Technical Analysis Sentiment
Negative
Last Price39.98
Price Trends
50DMA
26.54
Negative
100DMA
33.49
Negative
200DMA
51.38
Negative
Market Momentum
MACD
-1.74
Positive
RSI
38.03
Neutral
STOCH
25.13
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2145, the sentiment is Negative. The current price of 39.98 is above the 20-day moving average (MA) of 24.83, above the 50-day MA of 26.54, and below the 200-day MA of 51.38, indicating a bearish trend. The MACD of -1.74 indicates Positive momentum. The RSI at 38.03 is Neutral, neither overbought nor oversold. The STOCH value of 25.13 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2145.

Shanghai Chicmax Cosmetics Co., Ltd. Class H Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
HK$8.88B11.0825.72%6.30%23.19%-22.44%
65
Neutral
HK$24.66B8.6010.98%7.54%2.19%10.78%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
HK$21.03B-230.49-1.21%4.23%-2.44%81.73%
50
Neutral
HK$126.67M-6.43-13.48%15.79%-9.95%-834.42%
46
Neutral
HK$920.97M-16.20-12.81%0.53%13.43%7.72%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2145
Shanghai Chicmax Cosmetics Co., Ltd. Class H
22.30
-72.21
-76.40%
HK:1044
Hengan International Group Co
21.24
-1.45
-6.41%
HK:0157
Natural Beauty Bio-Technology
0.46
-0.10
-17.86%
HK:6993
Blue Moon Group Holdings Ltd.
3.78
0.61
19.28%
HK:2593
Herbs Generation Group Holdings Limited Class H
0.95
-0.37
-28.03%
HK:6883
Eternal Beauty Holdings Limited
2.03
-0.06
-2.87%

Shanghai Chicmax Cosmetics Co., Ltd. Class H Corporate Events

Shanghai Chicmax Sets Board Meeting to Approve 2026 Interim Results
Aug 17, 2026
Shanghai Chicmax Cosmetic Co., Ltd., a Hong Kong-listed PRC cosmetics group, develops and sells beauty and personal care products across its subsidiaries, serving consumers primarily in China and potentially the wider Asian market. The company ope...
Shanghai Chicmax Warns of Steep First-Half Profit Drop on KANS Slump and Strategic Investments
Aug 17, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has warned that its revenue for the six months ended June 30, 2026 is expected to fall to about RMB3.72 billion–RMB3.76 billion, down roughly 8.5%–9.5% year on year. Over the same period, profit is f...
Shanghai Chicmax boosts stake in child skincare unit Shanghai Yiye
Aug 11, 2026
Shanghai Chicmax Cosmetics has moved to increase its stake in its non-wholly owned subsidiary Shanghai Yiye, agreeing for its unit Shanghai Qingdao to acquire equity interests from connected parties Dajiao Investment and Ms. Liu. The deals, totali...
Shanghai Chicmax Updates Articles to Reflect New RSU-Driven Share Capital
Jul 29, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has updated its articles of association to reflect changes in registered share capital following the recent grant of restricted share units under its RSU Scheme. After the issue and allotment of 148,529 H shares...
Shanghai Chicmax Proposes Elevating Vice President Wang Tao to Executive Director
Jul 3, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has proposed appointing vice president Wang Tao as an executive director of its second board session, following a recommendation from the nomination committee and subject to shareholder approval at an upcoming e...
Shanghai Chicmax Grants Sixth Round of Restricted Share Units to Directors and Staff
Jul 2, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has executed a sixth round grant of 182,304 restricted share units, equal to 0.09% of its issued share capital, to 13 grantees including two executive directors and 11 employees. The RSUs, priced at RMB1.00 per ...
Shanghai Chicmax Announces Resignation of Executive Director Zhou Wei
Jun 30, 2026
Shanghai Chicmax Cosmetics Co., Ltd., a Hong Kong-listed PRC cosmetics manufacturer and marketer under stock code 2145, serves the Chinese beauty and personal care market with a board comprising executive, employee representative and independent n...
Shanghai Chicmax Clarifies Board Structure and Committee Roles
Jun 30, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has disclosed an updated list of its directors and clarified their roles and functions on the board. The structure includes executive directors, an employee representative director, and independent non-executive...
Shanghai Chicmax Board to Weigh Director Election and H-Share Buyback
Jun 30, 2026
Shanghai Chicmax Cosmetic Co., Ltd. has scheduled a board meeting for July 3, 2026 to address key governance matters related to its leadership and capital structure. The Board will consider the election of a new director, a move that could adjust ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 19, 2026